Asthma: Chronopharmacotherapy and the molecular clock

Bronchial asthma is characterized by chronic airways inflammation and reversible airflow limitation. In patients with asthma, symptoms generally worsen during the early hours of the morning, and pulmonary function often deteriorates at the same time, suggesting a role for chronopharmacotherapy. Seve...

Full description

Saved in:
Bibliographic Details
Published inAdvanced drug delivery reviews Vol. 62; no. 9; pp. 946 - 955
Main Authors Burioka, Naoto, Fukuoka, Yasushi, Koyanagi, Satoru, Miyata, Masanori, Takata, Miyako, Chikumi, Hiroki, Takane, Hiroshi, Watanabe, Masanari, Endo, Masahiro, Sako, Takanori, Suyama, Hisashi, Ohdo, Shigehiro, Shimizu, Eiji
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier B.V 31.07.2010
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Bronchial asthma is characterized by chronic airways inflammation and reversible airflow limitation. In patients with asthma, symptoms generally worsen during the early hours of the morning, and pulmonary function often deteriorates at the same time, suggesting a role for chronopharmacotherapy. Several drugs for asthma have been developed based on chronopharmacology. Most medications employed for the chronotherapy of asthma are administered once at night with the goal of preventing chronic airway inflammation or development of airflow limitation. In addition to bronchodilators, the inhaled glucocorticosteroid ciclesonide is now available with once-daily dosing, which also improves patients' compliance. Numerous investigations have demonstrated the usefulness of chronotherapy for asthma, especially for patients with nocturnal asthma. This review focuses on chronotherapy of asthma, and also provides a molecular biological explanation for the influence of asthma medications on the clock genes.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
ObjectType-Feature-1
ISSN:0169-409X
1872-8294
DOI:10.1016/j.addr.2010.03.012